Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effects of High-Dose Vitamin C in Patients with Severe Burns
FranceStudy on the Safety and Tolerability of VGL101 for Adults with Adult-Onset Leukoencephalopathy
FranceStudy on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B
FranceStudy Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence
FranceStudy on GSK3858279 for Adults with Chronic Diabetic Nerve Pain
FranceStudy on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer
FranceStudy on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer
FranceStudy on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions
FranceStudy of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
FranceStudy on the Effectiveness of Ompenaclid with FOLFIRI and Bevacizumab for Patients with Advanced or Metastatic Colorectal Cancer
FranceStudy of Pembrolizumab and Lenvatinib with TACE for Patients with Incurable Non-metastatic Liver Cancer
FranceStudy on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
